These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 38825234

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Frozen storage of proteins: Use of mannitol to generate a homogenous freeze-concentrate.
    Sonje J, Chisholm CF, Suryanarayanan R.
    Int J Pharm; 2023 Jan 05; 630():121995. PubMed ID: 35809832
    [Abstract] [Full Text] [Related]

  • 23. Application of a mixture DOE for the prediction of formulation critical temperatures during lyophilisation process optimisation.
    Gervasi V, Cullen S, McCoy T, Crean A, Vucen S.
    Int J Pharm; 2019 Dec 15; 572():118807. PubMed ID: 31678526
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Freeze-drying of mannitol-trehalose-sodium chloride-based formulations: the impact of annealing on dry layer resistance to mass transfer and cake structure.
    Lu X, Pikal MJ.
    Pharm Dev Technol; 2004 Dec 15; 9(1):85-95. PubMed ID: 15000469
    [Abstract] [Full Text] [Related]

  • 26. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P, Gieseler H, Gieseler M, Abdul-Fattah AM, Adler M, Mahler HC, Goldbach P.
    J Pharm Sci; 2015 Dec 15; 104(12):4241-4256. PubMed ID: 26422647
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Freeze-concentration separates proteins and polymer excipients into different amorphous phases.
    Izutsu K, Kojima S.
    Pharm Res; 2000 Oct 15; 17(10):1316-22. PubMed ID: 11145240
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes.
    Her LM, Deras M, Nail SL.
    Pharm Res; 1995 May 15; 12(5):768-72. PubMed ID: 7479566
    [Abstract] [Full Text] [Related]

  • 32. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.
    Izutsu KI.
    Adv Exp Med Biol; 2018 May 15; 1081():371-383. PubMed ID: 30288720
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
    Horn J, Schanda J, Friess W.
    Eur J Pharm Biopharm; 2018 Jun 15; 127():342-354. PubMed ID: 29522899
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
    Beirowski J, Inghelbrecht S, Arien A, Gieseler H.
    J Pharm Sci; 2011 Oct 15; 100(10):4471-81. PubMed ID: 21607957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.